Growth Differentiation Factor 15 in Multiple Myeloma: A Microenvironment Factor Predictive of Response to Treatment?

Publisher： Karger

E-ISSN： 1421-9662|131|3|170-172

ISSN： 0001-5792

Source： Acta Haematologica, Vol.131, Iss.3, 2013-11, pp. : 170-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Serum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-11 ,pp. : 173-178

Karger

Access to resources Recommend Favorite

Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 5, 2015-11 ,pp. : 814-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Growth differentiation factor 15 (GDF‐15) in patients admitted for acute heart failure: results from the RELAX‐AHF study

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1133-1143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple myeloma relapse in the irradiated liver: involvement of hepatocyte growth factor akin to that after hepatocyte transplantation

By  

Journal of Radiotherapy in Practice, Vol. 11, Iss. 4, 2012-05 ,pp. : 271-273

Cambridge University Press

Access to resources Recommend Favorite

Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects

By Eggers Kai M.   Kempf Tibor   Lind Lars   Sundström Johan   Wallentin Lars   Wollert Kai C.   Siegbahn Agneta  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 1, 2012-02 ,pp. : 45-51

Informa Healthcare

Access to resources Recommend Favorite